statistiche ricercatore

Continente	#
NA - Nord America	388
AS - Asia	300
EU - Europa	244
SA - Sud America	39
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	5
OC - Oceania	2
Totale	1.007

Città	#
Singapore	101
Chandler	67
Dublin	51
Hong Kong	37
San Jose	26
Jacksonville	24
San Mateo	24
Dong Ket	19
Santa Clara	19
Ashburn	17
Munich	14
Seoul	14
Altamura	12
Boardman	11
Medford	10
Princeton	10
The Dalles	10
Beijing	9
Lauterbourg	9
Wilmington	9
Andover	8
Ho Chi Minh City	8
Lawrence	8
Moscow	8
Los Angeles	7
New York	6
Hanoi	5
São Paulo	5
Tokyo	4
Brussels	3
Cormano	3
Poplar	3
Toronto	3
Amelia	2
Amsterdam	2
Ann Arbor	2
Atlanta	2
Brno	2
Chennai	2
Denver	2
Guayaquil	2
Haiphong	2
Izmir	2
Johannesburg	2
Lahore	2
Livorno	2
Manchester	2
Mcallen	2
Orem	2
Perugia	2
Piscataway	2
Riyadh	2
Rome	2
Shanghai	2
Tashkent	2
Turku	2
Warsaw	2
Acerra	1
Ahmedabad	1
Amparo	1
Ankara	1
Annapolis	1
Araure	1
Auckland	1
Azcapotzalco	1
Baghdad	1
Barra do Garças	1
Biên Hòa	1
Bloomfield Hills	1
Bogotá	1
Borrazópolis	1
Boydton	1
Brooklyn	1
Bryan	1
Canton	1
Carmópolis	1
Casablanca	1
Changsha	1
Charlotte	1
Chicago	1
Chisinau	1
Columbus	1
Conceição das Alagoas	1
Corpus Christi	1
Curitiba	1
Da Nang	1
Decatur	1
Diamantina	1
Divino	1
Figueira da Foz Municipality	1
Florence	1
Florianópolis	1
Fortaleza	1
Frankfurt am Main	1
Groningen	1
Guarulhos	1
Guatemala City	1
Gunzenhausen	1
Hayward	1
Helsinki	1
Totale	655

Nome	#
a-Amino-b-carboxymuconate-e-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of de Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis	129
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?	122
Bulky 1,4-benzoxazine derivatives with antifungal activity	119
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids.	100
Use of an o-Benzyl-(S)-Serine Containing Eluent for the Efficient Ligand-Exchange Chromatography-Based Enantioseparation of Constrained Glutamate Receptor Ligands	96
Targeting the Conformational Transitions of MDM2 and MDMX. PART II: Insights into Key Residues Affecting p53 Recognition.	92
Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition.	91
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4).	90
Targeting the Conformational Transitions of MDM2 and MDMX. PART I: Insights into Dissimilarities and Similarities of p53 Recognition	87
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition	81
Totale	1.007

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	52	0	0	0	0	1	0	0	29	0	2	10	10
2022/2023	177	10	37	2	15	16	18	0	7	63	0	7	2
2023/2024	73	3	12	3	1	2	0	11	0	16	1	13	11
2024/2025	155	7	14	18	4	10	17	0	3	29	9	24	20
2025/2026	338	22	31	12	45	52	29	54	22	35	23	11	2
2026/2027	31	16	7	8	0	0	0	0	0	0	0	0	0
Totale													1.007

IRIS - Res&Arch Institutional Research Information System - Research & Archive